CEF19, Epstein-Barr Virus latent NA-3A (458-466)

CEF19 is a synthetic HLA-B35-restricted T-cell epitope derived from Epstein-Barr virus latent nuclear antigen 3A, spanning residues 458–466. This peptide is widely used to study EBV-specific CD8⁺ T-cell immunity during latent infection. CEF19 supports investigations into antigen processing, immune surveillance, cellular immune responses, and EBV-associated malignancy mechanisms. Common applications include immune monitoring assays, epitope mapping, T-cell activation studies, and evaluation of T-cell-based therapeutic strategies targeting EBV persistence and latency. It is a valuable peptide reagent for herpesvirus immunology and HLA-restricted adaptive immune research.

Product Name: CEF19, Epstein-Barr Virus latent NA-3A (458-466)

Sequence One Letter Code: YPLHEQHGM

Sequence Three Letter Code: H-Tyr-Pro-Leu-His-Glu-Gln-His-Gly-Met-OH

Chemical Formula:C49H70N14O14S

Molecular Weight: 1111.3

Purity: ≥ 95%

Form: Lyophilized

Storage Conditions: - 20 °C

Source / Species: EBV

Conjugation: Unconjugated

Code Nacres: NA.26